Bio-Rad Laboratories, Inc. BIO.B Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $108.1M-16.8% | $164.9M+32.8% | $120.9M-26.1% | $116.5M+19.4% | $129.9M+86.1% | ||
| $30M-12.8% | $45.8M+6.8% | $31.7M-21.1% | $45.7M+8.0% | $34.4M-14.4% | ||
| $226.1M+47.4% | $138.8M-37.7% | $223.9M-43.9% | $153.2M-38.2% | $153.4M-62.3% | ||
| $145.1M-15.2% | $147.4M-28.3% | $200.6M-44.9% | $274.4M+33.9% | $171.2M-48.4% | ||
| $100K— | —— | —— | $100K+35.1% | $0-100% | ||
| -$93.2M-3,314% | -$34.2M-12.1% | -$43M+22.8% | -$115.4M-273% | $2.9M+107% | ||
| $47.8M-53.1% | $0— | $53.4M-45.5% | $140.2M+38.8% | $101.9M+2,068% | ||
| $100K0.0% | $200K— | $0-100% | $200K+100% | $100K-50.0% | ||
| $3.4M-20.9% | $3.9M0.0% | $3.4M-33.3% | $4.2M-10.6% | $4.3M-21.8% | ||
| -$44M+55.0% | $0+100% | -$52.5M+45.3% | -$136.3M-41.1% | -$97.7M— | ||
| $5.9M+428% | —— | —— | -$16.2M-526% | -$1.8M-167% | ||
| -$23.2M-170% | $134M+72.7% | $26.5M+489% | -$151.4M— | $33.3M+13.3% | ||
| $22.4M+0.9% | $1.1M+22.2% | $22.4M+0.4% | $900K0.0% | $22.2M-0.9% | ||
| $11M+39.2% | $7.3M-69.2% | $0-100% | $48.2M-0.4% | $7.9M+108% | ||
| $515.8M+5.7% | $547.5M+3.9% | $517.5M+15.9% | $505.9M-3.6% | $488M-12.9% | ||
| -$9.9M-219% | —— | $8.6M-45.6% | $26M+386% | $8.3M+477% | ||
| $614.1M-4.0% | $697.7M+10.4% | $653.8M-0.3% | $664.9M+6.0% | $640M+0.3% | ||
| $33.3M+104% | $18.3M-3.7% | $13.8M-14.3% | $32.6M-7.4% | $16.3M+3.2% | ||
| —— | -$9.53M-290% | -$9.53M-290% | -$9.53M-290% | -$9.53M-290% | ||
| $17.7M-9.2% | $3M-89.9% | $13.8M-68.0% | $25.7M-52.7% | $19.5M-73.0% | ||
| $145.1M-15.2% | $147.4M-28.3% | $200.6M-44.9% | $274.4M+33.9% | $171.2M-48.4% | ||
| $100K— | —— | —— | $100K+35.1% | $0-100% | ||
| $500K— | —— | —— | —— | $0— | ||
| —— | $3.95M-17.7% | $3.95M-17.7% | $3.95M-17.7% | $3.95M-17.7% | ||
| —— | $11.65M+0.2% | $11.65M+0.2% | $11.65M+0.2% | $11.65M+0.2% | ||
| $11M+39.2% | $7.3M-69.2% | $0-100% | $48.2M-0.4% | $7.9M+108% | ||
| $78.1M-18.2% | $119.1M+46.5% | $89.2M-27.7% | $70.8M+28.0% | $95.5M+223% | ||
| $78.1M-18.2% | $119.1M+46.5% | $89.2M-27.7% | $70.8M+28.0% | $95.5M+223% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories, Inc. generate?
- Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories, Inc.'s free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
